Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin Effect on Mitochondrial and Endothelial Function in Type 2 Diabetes
NCT01969084Phase 4Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Beth Israel Deaconess Medical Center. Started Oct 2013; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01969084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969084.